KEROS THERAPEUTICS INC (KROS) Stock Analyst Ratings
NASDAQ:KROS - Nasdaq - US4923271013 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to KROS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 46.92. This target is 332.04% above the current price.
KROS was analyzed by 20 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about KROS.
In the last month the buy percentage fell by 6 points. So the trust of analysts is decreasing.
KROS was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-17 | Guggenheim | Reiterate | Neutral -> Neutral |
| 2025-01-17 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-01-17 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-01-16 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-01-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-23 | Truist Securities | Maintains | Buy -> Buy |
| 2024-12-16 | Guggenheim | Downgrade | Buy -> Neutral |
| 2024-12-16 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-12-13 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-12-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-12 | TD Cowen | Downgrade | Buy -> Hold |
| 2024-12-12 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-12-12 | BTIG | Downgrade | Buy -> Neutral |
| 2024-12-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-12-05 | Guggenheim | Maintains | Buy -> Buy |
| 2024-12-04 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-11-22 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-11-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-24 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-10-16 | ScotiaBank | Initiate | Sector Outperform |
| 2024-09-23 | Guggenheim | Initiate | Buy |
| 2024-09-12 | B of A Securities | Maintains | Buy -> Buy |
| 2024-06-25 | Oppenheimer | Initiate | Outperform |
| 2024-06-18 | Truist Securities | Maintains | Buy -> Buy |
| 2024-06-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-09 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-03-13 | Truist Securities | Reiterate | Buy -> Buy |
| 2024-03-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-08 | Wells Fargo | Initiate | Overweight |